Clinical trial
Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.
NCT02821169 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.
- Lead sponsor
- University Hospital, Lille
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- June 30, 2019
- Enrollment
- 184 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.